Tinnitus Clinical Trial
Official title:
Cost-effectiveness of Multidisciplinary Management of Tinnitus at a Specialised Tinnitus Centre
Background: Tinnitus is a common chronic health condition that affects 10% to 20% of the
general population. Among severe sufferers it causes disability in various areas. As a
result of the tinnitus quality of life is often impaired. At present there is no cure or
uniformly effective treatment, leading to fragmentized and costly tinnitus care. Evidence
suggests an integral multidisciplinary approach in treating tinnitus is effective. The main
objective of this study is to examine the effectiveness, costs, and cost-effectiveness of an
integral treatment provided by a specialized tinnitus center versus usual care. This paper
describes the study protocol.
Methods/Design: In a randomized controlled clinical trial 198 tinnitus patients will be
randomly assigned to a specialized tinnitus care group or a usual care group. Adult tinnitus
sufferers referred to the audiological centre are eligible. Included patients will be
followed for 12 months.
Primary outcome measure is generic quality of life (measured with the Health Utilities Index
Mark III). Secondary outcomes are severity of tinnitus, general distress, tinnitus
cognitions, tinnitus specific fear, and costs. Based on health state utility outcome data
the number of patients to include is 198. Economic evaluation will be from a societal
perspective.
Discussion/ Conclusion: This is, to our knowledge, the first randomized controlled trial
that evaluates an integral treatment of tinnitus that includes a full economic evaluation
from a societal perspective. If this intervention proves to be effective and cost-effective,
implementation of this intervention is considered and anticipated.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Recruiting |
NCT04987502 -
Virtual Reality and Subjective Tinnitus
|
N/A | |
Recruiting |
NCT04404439 -
Treatment of Tinnitus With Migraine Medications
|
Phase 4 | |
Recruiting |
NCT05533840 -
Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
|
||
Completed |
NCT03552302 -
Effects of Yoga Exercise on Participates With Tinnitus
|
||
Enrolling by invitation |
NCT02617953 -
Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus
|
N/A | |
Completed |
NCT02269839 -
A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus
|
N/A | |
Withdrawn |
NCT01663467 -
Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
|
N/A | |
Completed |
NCT02974543 -
Somatosensory Stimulation to Alleviate Tinnitus
|
N/A | |
Completed |
NCT01929837 -
Tinnitus rTMS 2013
|
N/A | |
Completed |
NCT01927991 -
Internet-based Self-help for Tinnitus: The Role of Support
|
N/A | |
Completed |
NCT01857661 -
The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial
|
N/A | |
Completed |
NCT01480193 -
New Therapy for Patients With Severe Tinnitus
|
N/A | |
Terminated |
NCT01412918 -
Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression
|
N/A | |
Completed |
NCT00748475 -
Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus
|
N/A | |
Completed |
NCT00371436 -
Progressive Intervention Program for Tinnitus Management
|
N/A | |
Active, not recruiting |
NCT05518682 -
Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus
|
N/A | |
Recruiting |
NCT05212298 -
Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus
|
N/A | |
Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 | |
Active, not recruiting |
NCT03336398 -
Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus
|
Phase 2 |